283 related articles for article (PubMed ID: 36011183)
1. Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?
Nappi RE; Martella S; Albani F; Cassani C; Martini E; Landoni F
Healthcare (Basel); 2022 Aug; 10(8):. PubMed ID: 36011183
[TBL] [Abstract][Full Text] [Related]
2. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.
Faubion SS; Larkin LC; Stuenkel CA; Bachmann GA; Chism LA; Kagan R; Kaunitz AM; Krychman ML; Parish SJ; Partridge AH; Pinkerton JV; Rowen TS; Shapiro M; Simon JA; Goldfarb SB; Kingsberg SA
Menopause; 2018 Jun; 25(6):596-608. PubMed ID: 29762200
[TBL] [Abstract][Full Text] [Related]
3. Management of genitourinary syndrome of menopause in breast cancer survivors: An update.
Lubián López DM
World J Clin Oncol; 2022 Feb; 13(2):71-100. PubMed ID: 35316932
[TBL] [Abstract][Full Text] [Related]
4. Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.
Nappi RE; Martini E; Cucinella L; Martella S; Tiranini L; Inzoli A; Brambilla E; Bosoni D; Cassani C; Gardella B
Front Endocrinol (Lausanne); 2019; 10():561. PubMed ID: 31496993
[TBL] [Abstract][Full Text] [Related]
5. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
The NAMS 2020 GSM Position Statement Editorial Panel
Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
[TBL] [Abstract][Full Text] [Related]
6. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.
Crean-Tate KK; Faubion SS; Pederson HJ; Vencill JA; Batur P
Am J Obstet Gynecol; 2020 Feb; 222(2):103-113. PubMed ID: 31473229
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update.
Merlino L; D'Ovidio G; Matys V; Piccioni MG; Porpora MG; Senatori R; Viscardi MF; Vitale A; Della Rocca C; On Behalf Of Policlinico Umberto I Collaborators
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111307
[TBL] [Abstract][Full Text] [Related]
8. Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?
Biglia N; Bounous VE; Sgro LG; D'Alonzo M; Pecchio S; Nappi RE
Clin Breast Cancer; 2015 Dec; 15(6):413-20. PubMed ID: 26198332
[TBL] [Abstract][Full Text] [Related]
9. The role of hormone therapy in urogenital health after menopause.
Nappi RE; Cucinella L; Martini E; Cassani C
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101595. PubMed ID: 34711512
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Jha S; Wyld L; Krishnaswamy PH
Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415
[TBL] [Abstract][Full Text] [Related]
11. Use of a vaginal CO
Mejia-Gomez J; Bouteaud J; Philippopoulos E; Wolfman W; Brezden-Masley C
Climacteric; 2022 Jun; 25(3):228-234. PubMed ID: 34694948
[TBL] [Abstract][Full Text] [Related]
12. Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy.
Cucinella L; Tiranini L; Cassani C; Martella S; Nappi RE
Int J Womens Health; 2023; 15():1261-1282. PubMed ID: 37576184
[TBL] [Abstract][Full Text] [Related]
13. The Genitourinary Syndrome of Menopause: An Overview of the Recent Data.
Angelou K; Grigoriadis T; Diakosavvas M; Zacharakis D; Athanasiou S
Cureus; 2020 Apr; 12(4):e7586. PubMed ID: 32399320
[TBL] [Abstract][Full Text] [Related]
14. Genitourinary Syndrome of Menopause: Management Strategies for the Clinician.
Faubion SS; Sood R; Kapoor E
Mayo Clin Proc; 2017 Dec; 92(12):1842-1849. PubMed ID: 29202940
[TBL] [Abstract][Full Text] [Related]
15. Fractional CO₂ vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors.
Siliquini GP; Bounous VE; Novara L; Giorgi M; Bert F; Biglia N
Breast J; 2021 May; 27(5):448-455. PubMed ID: 33728801
[TBL] [Abstract][Full Text] [Related]
16. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study.
Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto C;
Climacteric; 2018 Apr; 21(2):167-173. PubMed ID: 29411644
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
18. Female Pelvic Conditions: Genitourinary Syndrome of Menopause.
Brady PH; Gin GT; Rosenblum E; Wilkinson LD
FP Essent; 2022 Apr; 515():32-42. PubMed ID: 35420405
[No Abstract] [Full Text] [Related]
19. Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review.
Jugulytė N; Žukienė G; Bartkevičienė D
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676756
[TBL] [Abstract][Full Text] [Related]
20. Genitourinary Syndrome of Menopause: A Narrative Review Focusing on Its Effects on the Sexual Health and Quality of Life of Women.
Wasnik VB; Acharya N; Mohammad S
Cureus; 2023 Nov; 15(11):e48143. PubMed ID: 38046779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
